Related Experiment Video
Updated: Oct 9, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Treatment of advanced breast cancer with gemcitabine and vinorelbine
1Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. ghortoba@mail.mdanderson.org
Abstract:
Breast cancer is sensitive to several cytotoxic drugs. Combination cytotoxic regimens are associated with higher response rates and longer durations of response and, occasionally, survival, than are single-agent regimens. However, combination regimens of conventional agents have not changed the course of the disease. In the past decade, numerous newer cytotoxic agents have been developed. Gemcitabine (Gemzar) and vinorelbine (Navelbine) are two such newer agents that have demonstrated good antitumor activity and favorable toxicity profiles as single-agent therapy for advanced breast cancer. Because gemcitabine and vinorelbine have different mechanisms of antitumor activity and good therapeutic indices, they have been evaluated as a combination regimen for the treatment of advanced breast cancer. Data from phase II clinical trials suggest that the combination of gemcitabine and vinorelbine with or without granulocyte colony-stimulating factor is effective first- or second-line therapy for advanced breast cancer and has a favorable safety profile. Further studies of the gemcitabine/vinorelbine combination regimen are warranted.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...